|
HY-103032-10mg
|
MedChemexpress LLC
|
Mu lti-kinase inhibitor 1 [CAS 778274-97-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-103032-100mg
|
MedChemexpress LLC
|
Mu lti-kinase inhibitor 1 [CAS 778274-97-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-103032-25mg
|
MedChemexpress LLC
|
Mu lti-kinase inhibitor 1 [CAS 778274-97-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-103032-5mg
|
MedChemexpress LLC
|
Mu lti-kinase inhibitor 1 [CAS 778274-97-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-103032-50mg
|
MedChemexpress LLC
|
Mu lti-kinase inhibitor 1 [CAS 778274-97-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99181-1mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
|
HY-P99181-10mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
|
HY-P99181-5mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
|
HY-Y1080-100mg
|
MedChemexpress LLC
|
N-Acetyl-R-leucine [CAS 19764-30-8]
|
|
|
|
|
HY-Y1080-250mg
|
MedChemexpress LLC
|
N-Acetyl-R-leucine [CAS 19764-30-8]
|
|
|
|
|
HY-Y1080-50mg
|
MedChemexpress LLC
|
N-Acetyl-R-leucine [CAS 19764-30-8]
|
|
|
|
|
HY-Y1080-500mg
|
MedChemexpress LLC
|
N-Acetyl-R-leucine [CAS 19764-30-8]
|
|
|
|
|
HY-D1683-10mg
|
MedChemexpress LLC
|
NBD-PE [CAS 178119-00-1]
|
|
|
|
|
HY-D1683-5mg
|
MedChemexpress LLC
|
NBD-PE [CAS 178119-00-1]
|
|
|
|
|
HY-128974-100mg
|
MedChemexpress LLC
|
N-Dodecyl-Beta-D-maltoside [CAS 69227-93-6]
|
|
|
|
|
HY-128974-500mg
|
MedChemexpress LLC
|
N-Dodecyl-Beta-D-maltoside [CAS 69227-93-6]
|
|
|
|
|
HY-128974-1mL
|
MedChemexpress LLC
|
N-Dodecyl-Beta-D-maltoside [CAS 69227-93-6] (10mM in DMSO)
|
|
|
|
|
HY-B0203A-10mg
|
MedChemexpress LLC
|
Nebivolol (hydrochloride) [CAS 152520-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0203A-100mg
|
MedChemexpress LLC
|
Nebivolol (hydrochloride) [CAS 152520-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0203A-5mg
|
MedChemexpress LLC
|
Nebivolol (hydrochloride) [CAS 152520-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0203A-50mg
|
MedChemexpress LLC
|
Nebivolol (hydrochloride) [CAS 152520-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0203A-500mg
|
MedChemexpress LLC
|
Nebivolol (hydrochloride) [CAS 152520-56-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0203A-1mL
|
MedChemexpress LLC
|
Nebivolol (hydrochloride) [CAS 152520-56-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-10619D-10mg
|
MedChemexpress LLC
|
Niraparib (R-enantiomer) [CAS 1038915-58-0]
|
|
Cancer-programmed cell death
|
|
|
HY-10619D-5mg
|
MedChemexpress LLC
|
Niraparib (R-enantiomer) [CAS 1038915-58-0]
|
|
Cancer-programmed cell death
|
|
